Online Tool Enables Communication of Genetic Testing Results With Family Members
via HealthDay TUESDAY, March 31, 2026 -- A new online tool may help cancer patients communicate genetic testing results with family, according to a study published online March 24 in the Journal of Clinical Oncology.
Steven J. Katz, M.D., from the University of Michigan in Ann Arbor, and colleagues evaluated an online, direct-to-family, cancer genetic education and communication tool (Genetic Information and Family Testing) among adult relatives of cancer survivors who carried a pathogenic variant. The analysis included 414 enrolled patients.
The researchers reported that enrolled patients reported a total of 4,946 first- and second-degree relatives (mean, 12.3) and that they invited 948 relatives (19.2 percent), of whom 32 percent enrolled. Most enrolled relatives ordered testing (91.3 percent). For relatives randomly assigned to free versus $50 testing, the odds of testing were 2.5-fold higher. However, the absolute increase was modest (0.04). Being randomly assigned to a human navigator did not increase testing (odds ratio, 1.3; 95 percent confidence interval, 0.8 to 2.1).
"Our online intervention is a promising blueprint to address this critical need for cascade genetic education and testing," Katz said in a statement. "Few medical tests have implications for others beyond the patient. But with germline genetic testing, the results can be very significant to the health of others around you."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-01 01:57
Read more
- Johnson & Johnson Therapy Nipocalimab Granted U.S. FDA Fast Track Designation in Systemic Lupus Erythematosus (SLE)
- FDA Approves Lynavoy (linerixibat) for Cholestatic Pruritus in Patients with Primary Biliary Cholangitis
- RFK Jr. Urges Medical Schools To Add More Nutrition Training
- Study Warns Fluoride Bans May Raise Tooth Decay in Children
- Rhythm Pharmaceuticals Announces FDA Approval of Imcivree (setmelanotide) for Patients with Acquired Hypothalamic Obesity
- AI Therapist? It Falls Short, a New Study Warns
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions